KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Margin (2016 - 2025)

Historic FCF Margin for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 24.02%.

  • Pfizer's FCF Margin rose 12500.0% to 24.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.16%, marking a year-over-year decrease of 24100.0%. This contributed to the annual value of 15.46% for FY2024, which is 74100.0% up from last year.
  • As of Q3 2025, Pfizer's FCF Margin stood at 24.02%, which was up 12500.0% from 8.19% recorded in Q2 2025.
  • In the past 5 years, Pfizer's FCF Margin ranged from a high of 122.19% in Q4 2023 and a low of 60.8% during Q3 2023
  • For the 5-year period, Pfizer's FCF Margin averaged around 27.49%, with its median value being 22.88% (2022).
  • In the last 5 years, Pfizer's FCF Margin crashed by -875700bps in 2023 and then soared by 426000bps in 2024.
  • Pfizer's FCF Margin (Quarter) stood at 105.2% in 2021, then fell by -23bps to 81.5% in 2022, then skyrocketed by 50bps to 122.19% in 2023, then crashed by -81bps to 22.77% in 2024, then rose by 6bps to 24.02% in 2025.
  • Its FCF Margin was 24.02% in Q3 2025, compared to 8.19% in Q2 2025 and 12.91% in Q1 2025.